Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.
Secondino S, Pedrazzoli P, Basso S, Bossi P, Bianco A, Imarisio I, Pagani A, De Cicco M, Muscianisi S, Casanova M, Morosi C, Bergamini C, Benazzo M, Cossu Rocca M, Perotti C, Baldanti F, Zecca M, Licitra LF, Comoli P.
Secondino S, et al. Among authors: baldanti f.
Front Immunol. 2023 Jul 11;14:1208475. doi: 10.3389/fimmu.2023.1208475. eCollection 2023.
Front Immunol. 2023.
PMID: 37497213
Free PMC article.